Received by email:

File: NR MDM Enters Into Definitive Agreement (3).docx

News Release                           April 17th, 2018, Kelowna, BC
Marapharm Ventures Inc. Enters into a Definitive Agreement to Expand Washington State Operations
Marapharm Ventures, Inc. (CSE: MDM) (OTCQX: MRPHF) (FSE: 2M0) ("Marapharm", "Company") announces that the Company has 
--->entered into a Definitive Agreement (the "Agreement"), to acquire certain operational assets and, potentially, land an
--->d water rights related to two cannabis producers and processors operating in Okanogan County, located in Washington St
--->ate.

The Agreement provides for the acquisition by Marapharm of certain operational assets useful in connection with cannab
--->is production and processing (including security cameras, fencing, and irrigation systems, as well as leases for the P
--->roperty and mobile office units) and the right of first refusal to acquire 20 acres of agricultural land, which is wel
--->l-suited to the production of outdoor cannabis (the "Property"). The Property also has access to two water wells and t
--->he right to draw water pursuant to a water rights certificate. 

In a parallel process, AlphaPheno (License Number 412104) ("WA Licensee") has negotiated an option to purchase one tie
--->r 2 and one tier 3 production and processing license (the "Licenses") located on the Property. The acquisition of the 
--->Licenses will enable AlphaPheno to produce an additional 40,000 sq. ft. of cannabis plant canopy. The purchase price f
--->or the assets and option is 4,000,000 shares of Marapharm Common Stock, equivalent to $2,760,000 CAD at the time of th
--->e execution of the LOI (see News Release dated March 26, 2018). The option to acquire the Licenses is subject to regul
--->atory approval by the Washington State Liquor and Cannabis Board.

Marapharm anticipates that the Licenses could produce, for the 2018 grow season, approximately 4,200 pounds of dry can
--->nabis and 933 pounds of bulk trim and shake, at an initial production cost of approximately $500,000.00. All productio
--->n costs are payable by Company except plant-related expenses, which are payable by the WA Licensee per Washington law.
---> This additional production will further solidify the financial position of AlphaPheno and provide significant additio
--->nal product to AlphaPheno's contemplated extraction facility.

Marapharm's CEO, Linda Sampson, stated, "We have been working diligently to complete our Washington facility and expan
--->d the processing features and functions at the site. This will enable our tenant and future tenants to diversify consu
--->mer product development and delivery and meet a growing demand.  We are mobilizing rapidly to expand the processing ca
--->pabilities of our Lynden, Washington facility to capture critical market share".

ABOUT MARAPHARM VENTURES INC.

www.marapharm.com

Marapharm is a publicly traded company investing in the medical and recreational cannabis space, since 2014. Marapharm
---> has rapidly expanded to include having cultivation, production and dispensary locations in the key North American sta
--->tes of Washington, Nevada, and California, and are seeking expansion opportunities worldwide. 
FOR FURTHER INFORMATION:
www.marapharm.com or Linda Sampson, CEO 778-583-4476 email info@marapharm.com
SOCIAL MEDIA:
Facebook: facebook.com/marapharm Twitter: twitter.com/marapharm Web Program: marapharm.tv
STOCK EXCHANGES:
Marapharm trades in Canada, ticker symbol MDM on the CSE, in the United States, ticker symbol MRPHF on the OTCQX, and 
--->in Europe, ticker symbol 2M0 on the FSE. Marapharm also trades on other recognized platforms in Europe including Stutt
--->gart, Tradegate, L & S, Quotnx, Dusseldorf, Munich, and Berlin.

Neither the CSE, the FSE nor the OTCQXtrademark has approved nor disapproved the contents of this press release. Neith
--->er the CSE, the FSE nor the OTCQXtrademark accepts responsibility for the adequacy or accuracy of this release.
MARIJUANA INDUSTRY INVOLVEMENT:
Canadian listings (CSE) will remain in good standing as long as they provide the disclosure that is rightly required b
--->y regulators and complying with applicable licensing requirements and the regulatory framework enacted by the applicab
--->le state in which they operate.
Marapharm owns marijuana licenses in California and Nevada. Marijuana is legal in each state however marijuana remains
---> illegal under US federal law and the approach to enforcement of US federal law against marijuana is subject to change
--->. Shareholders and investors need to be aware that adverse enforcement actions could affect their investments and that
---> Marapharm's ability to access private and public capital could be affected and or could not be available to support c
--->ontinuing operations. Marapharm's business is conducted in a manner consistent with state law and is in compliance wit
--->h licensing requirements.

Copies of licenses are posted on Marapharm's website. Marapharm has internal compliance procedures in place and has co
--->mpliance focused attorneys engaged in jurisdictions to monitor changes in laws for compliance with US federal and stat
--->e law on an ongoing basis. These law firms inform any necessary changes to our policies and procedures for compliance 
--->in Canada and the US.

FORWARD - LOOKING STATEMENTS:
Certain statements contained in this news release constitute forward looking statements. The use of any of the words "
--->anticipate", "continue", "estimate", "expect", 'may", "will", "project", "should", 'believe", and similar expressions 
--->are intended to identify forward- looking statements. These statements involve known and unknown risks, uncertainties 
--->and other factors that may cause actual results or events to differ materially from those anticipated in such forward-
---> looking statements are based on reasonable assumption but no assurance can be given that these expectations will prov
--->e to be correct and the forward-looking statements included in this news release should not be unduly relied upon.